SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Generation Bio Co. (GBIO) , forward earnings yield 9.92%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 10.1
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GBIO
Valuation Multiples
P/E (TTM)0.0
Forward P/E10.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio17.89
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.98
Forward EPS (Est.)$0.53
Book Value / Share$0.00
Revenue / Share$0.30
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield9.92%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-1.82 |
$36K |
$-35.8M |
-99452.8% |
| 2019 |
$-1.31 |
$0.00 |
$-60.33M |
- |
| 2020 |
$-2.81 |
$0.00 |
$-76.5M |
- |
| 2021 |
$-2.04 |
$0.00 |
$-114.67M |
- |
| 2022 |
$-2.27 |
$0.00 |
$-132.1M |
- |
| 2023 |
$-1.96 |
$5.9M |
$-126.61M |
-2144.5% |
| 2024 |
$-1.98 |
$19.89M |
$-131.67M |
-661.9% |
